Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.

scientific article published on May 2015

Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V21.I18.5524
P932PMC publication ID4427674
P698PubMed publication ID25987775

P2093author name stringCalvin Q Pan
Lillian Lou
Huy Trinh
Sing Chan
Ho Bae
Alan Yao
P2860cites workFibroTest-ActiTest as a non-invasive marker of liver fibrosisQ28299279
Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settingsQ28540372
EASL clinical practice guidelines: Management of chronic hepatitis B virus infectionQ29615868
Chronic hepatitis B: update 2009Q29617409
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyQ34317204
Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.Q35908687
Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral loadQ37346823
The management of chronic hepatitis B in Asian AmericansQ37936321
Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patientsQ38062304
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.Q39014100
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients.Q42251695
No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virusQ42693130
Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.Q42989166
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.Q46217486
P433issue18
P407language of work or nameEnglishQ1860
P921main subjecttenofovirQ155954
P304page(s)5524-5531
P577publication date2015-05-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleSimilar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.
P478volume21